i2o Therapeutics
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
610 Main St, Cambridge, Massachusetts, 0...Phone Number
(408) 476-1904Website
www.i2obio.comRevenue
$10.1 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About i2o Therapeutics
i2o Therapeutics specializes in next-generation biologics and peptides, focusing on GLP-1 combinations for obesity and cardio-renal-metabolic diseases. Their product pipeline includes long-acting GLP-1 receptor agonists, amylin DACRAs, PYY receptor agonists, and glucagon receptor agonists. The company aims to address significant health challenges through innovative therapeutic solutions. i2o Therapeutics is positioned to serve clients in the healthcare and pharmaceutical sectors.Explore more
i2o Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is i2o Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at i2o Therapeutics
Product Launch: Get notified when i2o Therapeutics launches new products
Check out if i2o Therapeutics is spiking on competitors!
Website visits: Recent activity has been detected on your website
i2o Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once i2o Therapeutics has new funding data
Earning: See what the market has to say on i2o Therapeutics recently announced quarterly report
Check if i2o Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Click to see if i2o Therapeutics had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined i2o Therapeutics as Masked Content
Find 3 more new buyers
Compare Similar Companies to i2o Therapeutics
Compare insights from companies similar to i2o Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
i2o Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
i2o Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about i2o Therapeutics.
i2o Therapeutics financials insights
Gather financial insights about i2o Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Other Financing Round
$46M
i2o Therapeutics Tech Stack
A closer look at the technologies used by i2o Therapeutics
Most Recent Scoops
Funding
New Hire
Executive Move
Board of Directors
Left Company
Executive Move
Executive Move
Board of Directors
Funding
Funding
i2o Therapeutics News & Media
i2O Therapeutics Announces the Appointment of Kurt C. Graves as Executive Chairman
BOSTON--(BUSINESS WIRE)--i2O Therapeutics announces the appointment of veteran biopharma leader Kurt Graves as Executive Chairman of its Board of Directors.i2O Therapeutics Announces Research Collaboration with Sanofi to Enable Oral Delivery of Nanobody-based Medicines
BOSTON--(BUSINESS WIRE)--i2O Therapeutics announces research collaboration with Sanofi focused on the oral delivery of the latter's Nanobody®-based medicines.i2O Therapeutics Receives Strategic Investment from Colorcon Ventures and Enters into Research Collaboration with Colorcon
BOSTON & HARLEYSVILLE, Pa.--(BUSINESS WIRE)--i2O Therapeutics announces strategic investment from and research collaboration with Colorcon.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding i2o Therapeutics
Sign Up For FreeTo access detailed company insights
i2o Therapeutics specializes in next-generation biologics and peptides, focusing on GLP-1 combinations for obesity and cardio-renal-metabolic diseases. Their product pipeline includes long-acting GLP-1 receptor agonists, amylin DACRAs, PYY receptor agonists, and glucagon receptor agonists. The company aims to address significant health challenges t... Read More
